US2503652A - Nu-phenethyl-beta-alanine derivatives - Google Patents

Nu-phenethyl-beta-alanine derivatives Download PDF

Info

Publication number
US2503652A
US2503652A US756335A US75633547A US2503652A US 2503652 A US2503652 A US 2503652A US 756335 A US756335 A US 756335A US 75633547 A US75633547 A US 75633547A US 2503652 A US2503652 A US 2503652A
Authority
US
United States
Prior art keywords
beta
methyl
alanine
hydroxy
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US756335A
Inventor
Baltzly Richard
Arthur P Phillips
Lowell O Randall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Burroughs Wellcome Co USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burroughs Wellcome Co USA filed Critical Burroughs Wellcome Co USA
Priority to US756335A priority Critical patent/US2503652A/en
Application granted granted Critical
Publication of US2503652A publication Critical patent/US2503652A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Definitions

  • Our invention relates to certain 'N-phenethyl-beta-alanine derivatives and is" based on the discovery that certain gN-phenethyl beta alanine esters and allrylolamides "have valuable physiological properties;especially in stimulating uterine smooth ,muscle without --acting as; general pfi'essor drugs, combined with low toxicities.
  • Another group of active substances consists ofgthe N-phenethyl -beta-alanine esters in which the beta-carbon of the phenethyl group (countingirom the nitrogen atom) is Substituted .with
  • the amine is treated with -an excess-of an ester of acrylic-acid, usually methyl acrylate, the reaction being-in the sense or the equationz-
  • the product so obtained is a tertiary base bases-so ob ain ca ib con te axicabs-desir d s lt b methods generally n n in e an.
  • the nature of the acid-employed isor dinarily of minor importancefor the physiological action but certain salts have physicalproperties making them more or less advantageous for puriiicat qn- .In. m s casesthe or de hav been used and th ar 1 gen all ef r ed butetber salts, such as the bromides; iodidejs 'l phosphates,
  • amines used in the preparation of the compounds according to the invention are well known in the art and their preparation does not form any part of the present invention.
  • methyl acrylate is the most readily available and has generally been employed.
  • the conversion of the beta-alanine methyl esters into higher alkyl esters can be accomplished conveniently by heating the methyl ester in a large excess of the appropriate higher alcohol containing anhydrous hydrogen chloride under a fractionating .column. During several hours heating, distillate is allowed to pass over gradually and an ester exchange takes place in the solution, the alkyl group of the higher alcohol replacing the methyl group in the ester.
  • N-methyl N (beta hydroxy beta-2,5-dimethoxyphenylethyl) beta-alanine ethyl ester hydrochloride 4.
  • N-methyl N -(beta-hydroxy-beta-phenylisopropyl) beta-alanine ethyl ester hydrochloride N-methyl N -(beta-hydroxy-beta-phenylisopropyl) beta-alanine ethyl ester hydrochloride.
  • R in a member of the group consisting of hydrogen and methyl R is a straight chain alkyl Containing from 1 to 5 carbon atoms and R and R are members of the group consisting of hydrogen, methyl, methoxy and ethoxy, and the salts thereof.
  • a new composition of matter selected from the group consisting of the compounds having I the following general formula R3 OH CH3 in which R is a straight chain alkyl containing from 1 to 5 carbon atoms, and the salts thereof.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

?1crystallization purification:
Patented Apr. 11, 1950 ()FFICEI N -PHENETHYL-BETA-LALAN1NE I DE I A E N9 'Iirawiiig App t n" unezzirlarz;
"The present application isf acqnti'nuation-j-in of our cO-pending applicationSeriallium;
194s "and both 'n'ow'abanjdoned.
Our invention relates to certain 'N-phenethyl-beta-alanine derivatives and is" based on the discovery that certain gN-phenethyl beta alanine esters and allrylolamides "have valuable physiological properties;especially in stimulating uterine smooth ,muscle without --acting as; general pfi'essor drugs, combined with low toxicities.
One group of compounds of this type {showing considerable potenci'es are the -compb lv ds in which the phenyl ring'is connected toitheni-tro gen by a pure hydrocarbon chain, and the phenyl ring bears two ethereal oxygen substituents, such as *two-"n'i'ethoxy groups-or a methylene l dioxy group,- these substances"forniing -the subject matter of our simultaneously filed companion application Serial No. 756,336 filed June 21, 1947.
Another group of active substances consists ofgthe N-phenethyl -beta-alanine esters in which the beta-carbon of the phenethyl group (countingirom the nitrogen atom) is Substituted .with
hydroxyl, with or Iwithout'methyl or alkoxy substituents in the phenylrmg. v
These compounds which form the-sub ect n'iattr' of the presentinventionimay' be represented "by the general forinulai IIU $113 cH-'oi1--N c11,crr5"-o'-om niiqwhiretire11sinn mbergen le- 2mm:arrestin ofhydfo'gen' a'n'd methyl; RF is a straight 'chain ;alkyl containing from 1 to 5 carbon atoms and R .ahdi R are' members of the "group "consisting? of i'iydrogen, methyl, methoiz 'y and iethoxy.
Theconipoundsaccording:-to the iinvention as represented in the general formula above, are
tei'tiai'yamines-which -ma be combined -=with vci'ious a'cids to "form salts for convenience ir-'1 handling and stability." 'The'natu'reof the=acids forming these acid saltsof the tertiary amines is ordinarily of noiniportance'ffor .the physiologi- =properties but may influenoe i' the :ease 1 of busin most cases salts of hydrochloric acid are-at least-as .lsatisfacto y as s t of ot er b i ds but so compounds have .been isolated more readily as sulieltes, ph sphates, tart ates; 1 ma t s, vsu
' drobromides,",ete. Su -variations-in animated a the "mannmation i 0rsaniciba esr ts-" em ni v ns hwi ena sist-ph vious; and 'we neithefconsider anypart of jour invention toconsist therein 'nordo we conceive that, any absencelof mention of the use 'ofsuch common acids shall be held to limit the "inveri tion. The'claimsappended hereto are intended to cover the tertiary bases as well as their acid salts:
is .reacted with a "beta-halogeno; usually a -betabromopropioniciester. This reaction is not unsatisfactory but since a separation of basic substances-isnecessary-and since only half (at most) of the m'ore valuableintermediate can be utilized we prefer a second line of synthesis;
According tothissecond method the amine is treated with -an excess-of an ester of acrylic-acid, usually methyl acrylate, the reaction being-in the sense or the equationz- The product so obtained is a tertiary base bases-so ob ain ca ib con te axicabs-desir d s lt b methods generally n n in e an. The nature of the acid-employed isor dinarily of minor importancefor the physiological action but certain salts have physicalproperties making them more or less advantageous for puriiicat qn- .In. m s casesthe or de hav been used and th ar 1 gen all ef r ed butetber salts, such as the bromides; iodidejs 'l phosphates,
In the first of these, the appropriate sulfates, oxalates, tartrates, succinates, malates, etc., have at times proved convenient.
The amines used in the preparation of the compounds according to the invention are well known in the art and their preparation does not form any part of the present invention.
Although other esters of acrylic acid than the methyl ester may be used in the second line of synthesis, methyl acrylate is the most readily available and has generally been employed. The conversion of the beta-alanine methyl esters into higher alkyl esters (corresponding to variations in R can be accomplished conveniently by heating the methyl ester in a large excess of the appropriate higher alcohol containing anhydrous hydrogen chloride under a fractionating .column. During several hours heating, distillate is allowed to pass over gradually and an ester exchange takes place in the solution, the alkyl group of the higher alcohol replacing the methyl group in the ester.
The following list of compounds prepared according to the invention is given by way of illustration, but is not intended as a limitation except as expressed in the claims:
1. N-methyl-N -(beta-hydroxy-beta-4-methylphenylethyl) beta-alanine methyl ester acid malate.
2. N methyl N -(beta-hydroxy beta-2,5-dimethylphenylethyl) beta-alanine methyl ester hydriodide. I
3. N-methyl N -(beta hydroxybeta-2,5-dimethoxyphenylethyl) beta-alanine methyl ester hydrochloride.
4. N-methyl N (beta hydroxy beta-2,5-dimethoxyphenylethyl) beta-alanine ethyl ester hydrochloride.
5. N-methyl N -(beta hydroxy beta-2,5-dimethoxyphenylethyl) beta-alanine n-butyl ester .acid oxalate.
6. N-methyl N (beta hydroxy beta 2,5-di methoxyphenylethyl) beta-alanine n-amyl ester acid oxalate.
'7. N-methyl N beta hydroxy beta-3,4-dimethoxyphenylethyl) beta-alanine methyl ester acid oxalate.
8. l-N-methyl N -(beta-hydroxy-beta-3,4-dimethoxyphenylethyl) beta-alanine methyl ester acid oxalate.
9. N-me'thyl N (beta hydroxy beta-3,4-dlmethoxyphenylethyl) beta alanine ethyl ester hydrobromide. I I
' 10. N-methyl N -(beta hydroxy-beta-2,5-diethoxyphenyl-ethyl) beta-alanine methyl ester hydrochloride.
11. N-methyl N (beta-hydroxy-beta-phenylisopropyl) beta-alanine methyl ester hydrochloride. I
12. N-methyl N -(beta-hydroxy-beta-phenylisopropyl) beta-alanine ethyl ester hydrochloride.
13. 1-N-methyl N (beta-hydroxy-beta-phenylisopropyl) beta-alanine ethyl ester hydrochloride.
14. N-methyl-N-(beta hydroxy-beta-Z-methoxy 5 methylphenylisopropyl) beta alanine methyl ester hydrochloride. I
' 15. N-methyl-N -(beta hydroxy beta-3,4 di- 'methoxyphenylisopropyl) beta alanine methyl ester hydrochloride.
16. d-N-methyl N -(beta hydroxy beta-3,4- dimethoxyphenylisopropyl) beta-alanine methyl ester hydrobromide. 1'7. N-methyl N -(beta hydroxy-beta-3A-dimethoxyphenylisopropyl) beta-alanine ethyl ester hydrochloride.
EXAMPLE 1 N-methyl-N-(beta-hydroacy-beta-2,5-dimethozyphenylethyl) beta-alanine ethyl ester hydrochloride Seventeen g. of beta-hydroxy-beta -(2,5-dimethoxy-phenyl)-ethylmethylamine hydrochloride (for preparation see Baltzly and Buck, J. Am. Chem. Soc. 62, 164 (1940)) was dissolved in water. The solution was basified and the liberated base i was taken into benzene and dried over potassium carbonate. The solution in about 200 cc. of benzene was allowed to stand sixty-four hours with 45 g. -of methyl acrylate and was then warmed on the steam-bath one-half hour. The solution was cooled and poured into acetone to which had been added 10 g. of a solutionof hydrogen chloride in methanol (39% by weight).. Absolute ether was added until the solution was not quite turbid. There crystallized 21 g. of the hydrochloride of Y N-methyl N -(beta-hydroxybeta 2,5 dimethoxyphenylethyl) beta-alanine methyl ester melting at 1545-155" .0. A recrystallization from methanol-acetone-ether mixture raised the melting point to 156-1565 C.,. the product then weighing 20.5 g. y
EXAMPLE 2 N -methyl-N (beta-hydrosry-beta -Zfi -dimethoa:yphenylethyl) beta-alanine ethyl ester hydro chloride Three g. of the corresponding methyl ester obtained according to Example 1 was dissolved in cc. of absolute ethanol to which was added lllg of 35% (by weight) ethanolic hydrogen chloride. The solution was refluxed four hours under a fractionating columnpermitting slow distillation. The solution was then evaporated nearly to dryness, diluted with ethyl acetate and ether and cooled. Colorless needles separated which melted at -6" C. Further crystallization did not raise the melting point and the analysis was correct for the ethyl ester hydrochloride.
EXAMPLE 3 N methyZ- N- (beta-hydromy-b6ta:2,5 -dimethomyphenylethyl) beta-alanine n-butyl ester acid oxalate 'Five g. of the corresponding methyl ester obtained according to Example l-was refluxed in n-butyl alcohol containing dissolved hydrogen chloride by the method of Example 2. The resulting n-butyl ester hydrochloride did not crystallize readily and the product was most-readily purified as the acid oxalate.
EXAMPLE 4 N -methyZ-N (beta-hydroxy-beta-3,4-dimethomyphenylethyl) beta-alanine methyl ester acid oxalate t-it Fifteen g. of beta-hydroxy beta-(3,4-dimetlioxyphenyl) ethylmethylamine (B. P., 152: at 1 mm.) was reacted by the method of Example 1 with 50 g. of methyl acrylate' The hydrochloride proved not to be readily crystallized and the product was transformed to'the acid "oxalate which crystallized from aqueous acetone-ether mixtures forming flattish prisms, M. P., 127- 128 C.
EXAMPLE 5 N methyl N (beta hydroxy beta phenylisopr-opyl) beta-alanine methyl ester hydrochloride EXAMPLE 6 N methyl N (beta hydromy beta. phenylisopropyl) beta-alanine ethyl ester hydrochloride Fifteen g. of d-l ephedrine hydrochloride was dissolved in water. The solution was basified and the ephedrine base was extracted with ether, the extract being dried over potassium carbonate. The ether was evaporated and to the residue (10.2 g.) was added 11.2 g. of ethyl beta-bromopropionate dissolved in 30 cc. of absolute ethanol. The solution was refluxed six hours and the ethanol was evaporated. The residue was dissolved in dilute hydrochloric acid, cooled and treated with a solution of 6 g. of sodium nitrite. The resulting nitroso derivative of the previously unreacted ephedrine was removed by extraction with ether and discarded. The aqueous layer was made strongly alkaline, extracted with ether and the ethereal extracts were dried over potassium carbonate. The ethereal solution was filtered from the desiccant and poured into an excess of hydrogen chloride dissolved in absolute alcohol, The hydrochloride of N-methyl-N-(beta-hydroxy-beta-phenylisopropy1) beta-alanine ethyl ester crystallized immediately.
EXAMPLE '7 1 -N-methyl-N- (be-ta-hydroxy-beta-phenylisopropyl) beta aldnine ethyl ester hydrochloride By the method of Example 6, l-ephedrine was reacted with ethyl acrylate to yield the desired product.
EXAMPLE 8 N methyl N (beta hydroxy beta 2 methoxy-5-methylphenyl isopropyl) beta-alanine methyl ester hydrochloride Five g. of beta-(2-methoxy-5-methylphenyl)- beta-hydroxy isopropyl methylamine hydrochloride (for preparation see Ardis, Baltzly and Schoen, J. Am. Chem. $00.68, 591 (1946)) was dissolved in water. The base Was liberated and treated with 5.1 g. of methyl acrylate according to the method of Example 1. The product, obtained in 84% yield, was crystallized from methanol-acetone-ether mixtures and melted at 179-180 C.
We claim:
1. A new composition of matter selected from the group consisting of the compounds having the following general formula:
in which R in a member of the group consisting of hydrogen and methyl, R is a straight chain alkyl Containing from 1 to 5 carbon atoms and R and R are members of the group consisting of hydrogen, methyl, methoxy and ethoxy, and the salts thereof.
2. A new composition of matter selected from the group consisting of the compounds having I the following general formula R3 OH CH3 in which R is a straight chain alkyl containing from 1 to 5 carbon atoms, and the salts thereof.
4. N methyl N (beta hydroxy beta 2,5- dimethoxyp-henylethyl)beta-alanine methyl ester hydrochloride.
5. N methy N (beta hydroxy beta 3,4- dimethoxyphenylethyl) beta-alanine methyl ester acid oxalate.
RICHARD BALTZLY. ARTHUR P. PHILLIPS. LOWELL O. RANDALL.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Name Date Peyer Jan. 21, 1941 OTHER REFERENCES J. R. Thayer et a1., Chem. Abst, vol. 22, page 81 (1928).
Number

Claims (1)

1. A NEW COMPOSITION OF MATTER SELECTED FROM THE GROUP CONSISTING OF THE COMPOUNDS HAVING THE FOLLOWING GENERAL FORMULA:
US756335A 1947-06-21 1947-06-21 Nu-phenethyl-beta-alanine derivatives Expired - Lifetime US2503652A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US756335A US2503652A (en) 1947-06-21 1947-06-21 Nu-phenethyl-beta-alanine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US756335A US2503652A (en) 1947-06-21 1947-06-21 Nu-phenethyl-beta-alanine derivatives

Publications (1)

Publication Number Publication Date
US2503652A true US2503652A (en) 1950-04-11

Family

ID=25043025

Family Applications (1)

Application Number Title Priority Date Filing Date
US756335A Expired - Lifetime US2503652A (en) 1947-06-21 1947-06-21 Nu-phenethyl-beta-alanine derivatives

Country Status (1)

Country Link
US (1) US2503652A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3280121A (en) * 1963-01-25 1966-10-18 Acraf Aminoalkylsydnones and a method for making them

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2229187A (en) * 1937-07-21 1941-01-21 Sandoz Ltd Amino-alcohol and a process for its production

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2229187A (en) * 1937-07-21 1941-01-21 Sandoz Ltd Amino-alcohol and a process for its production

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3280121A (en) * 1963-01-25 1966-10-18 Acraf Aminoalkylsydnones and a method for making them

Similar Documents

Publication Publication Date Title
US2676177A (en) Process for the preparation of optically active 3-methoxy-n-methyl morphinans and salts thereof
US3262977A (en) N-aralkyl-1, 1-diphenyl-propylamine derivatives
Harris et al. The Vitamin B6 Group. II. The Structure and Synthesis of Pyridoxamine and Pyridoxal1
US3957850A (en) Phenylacetic acid derivatives
Cline et al. Studies of crystalline vitamin B1. XVII. Synthesis of vitamin B1
Elliott 126. The stereochemistry of an oxazoline derivative of threonine. Improvement of a recent threonine synthesis
SE449358B (en) PROCEDURE FOR THE PREPARATION OF 4-AMINOHEX-5-ACID ACID OR SALTS THEREOF
Fodor et al. Use of acyl migration in separating diastereoisomeric amino alcohols
Wawzonek et al. The synthesis of 9, 10-dihydro-9, 10-(11-aminoethano) anthracenes
US2503652A (en) Nu-phenethyl-beta-alanine derivatives
US3557127A (en) Substituted cyclohexenes,derivatives thereof and processes for obtaining same
Toki Studies on sarkomycin–optically active 2-methylenecyclopentanone-3-carboxylic acids
US2538763A (en) Phenylaminopropandiols
RU2491278C2 (en) Heterocyclic indane derivatives used to control pain and treat glaucomoid state
CA1100513A (en) Arylaminoimidazoline derivatives and the preparation thereof
SE443784B (en) NEW ASSOCIATIONS WITH PHARMACOLOGICAL EFFECT
KR910002372B1 (en) Process for the preparation of diphenylimine derivatives
US2540946A (en) Pyridoxal-histamine and processes for preparing the same
FODOR et al. Configuration of diastereoisomeric 3-methoxy-4-hydroxyphenylpropanolamines
US2514377A (en) I-nitrophenyl
US2534567A (en) N-phenethyl-beta-alanine derivatives
US2903460A (en) Pyrazolone derivatives
Craig et al. Amine Exchange Reactions. Mannich Bases from Primary Aliphatic Amines and from Amino Acids1
Archer et al. 4-[(Aminoalkyl) amino]-1, 2-dimethoxynaphthalenes as antimalarial agents
US2098954A (en) Hydrouracil compounds and processes for their production